The global biotechnology CMO and CDMO market size is calculated at USD 74.01 billion in 2025 and is expected to reach around ...

Forget the industry terms "CDMO" and "CMO" when discussing cell therapy manufacturer Cellares. The South San Francisco-based company has coined its own acronym as the world’s first integrated ...

Crescita Therapeutics (OTCPK:CRRTF) has signed an amendment to its contract manufacturer supply agreement with its largest CMO client, a global skin care company. The amended pact bolsters Crescita's ...

DUBLIN--(BUSINESS WIRE)--The "Healthcare CMO Market: 2025 Edition" report has been added to ResearchAndMarkets.com's offering. The global healthcare CMO market was valued at US$145.83 billion in 2023, ...

LSL Pharma Group Inc ( ($TSE:LSL) ) has issued an announcement. LSL Pharma Group Inc. reported its fourth consecutive record quarterly revenues ...

Contract manufacturers have carved out a lucrative niche within the biopharma industry, and the value of their collective capacity and production agility was on full display during the COVID-19 ...

Celltrion Inc., Korea's leading biopharmaceutical company, said Wednesday it will invest 4 trillion won ($2.7 billion) in the country to expand its domestic facilities amid rising global demand for ...

TOKYO, June 5, 2025 /PRNewswire/ -- bitBiome, Inc., a biotechnology company unlocking the potential of our planet's microbes to power the future of the bioeconomy, today announced a new partnership ...

She explains how the company’s new corporate branding aims to underscore its commitment to trust and transparency in its partnerships with pharma.

DUBLIN--(BUSINESS WIRE)--The "Biopharmaceuticals Contract Manufacturing Market Report 2025-2035" has been added to ResearchAndMarkets.com's offering. World revenue for the Biopharmaceuticals Contract ...

Pharmaceutical maker Jubilant Pharmova, wholly owned subsidiary Jubilant Pharma Limited, through one of its wholly owned subsidiaries, Jubilant HollisterStier General Partnership, will invest $76.6 ...

ENGLEWOOD, CO / ACCESSWIRE / May 1, 2023 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (NASDAQ:AYTU), a commercial stage pharmaceutical and consumer health company providing pediatric-focused ...